AAPL299.43+2.42 (+0.81%) ▲|ABBV234.34+4.33 (+1.88%) ▲|ABT90.27+2.44 (+2.77%) ▲|ACN126.48+1.65 (+1.32%) ▲|ADBE196.81+1.91 (+0.98%) ▲|AMAT582.66-57.52 (-8.99%) ▼|AMD521.69-29.94 (-5.43%) ▼|AMGN347.21+2.49 (+0.72%) ▲|AMT176.94+0.51 (+0.29%) ▲|AMZN234.09+1.30 (+0.56%) ▲|AVGO380.98-11.16 (-2.84%) ▼|AXP337.82-0.26 (-0.08%) ▼|BA218.75-2.08 (-0.94%) ▼|BAC57.84+0.47 (+0.82%) ▲|BKNG167.94+0.17 (+0.10%) ▲|BLK1,030.89-20.85 (-1.98%) ▼|BMY55.38+0.68 (+1.24%) ▲|BNY147.98+1.54 (+1.05%) ▲|BRK-B493.71+5.02 (+1.03%) ▲|C145.82+0.15 (+0.10%) ▲|CAT986.47-35.82 (-3.50%) ▼|CL90.92+2.25 (+2.54%) ▲|CMCSA22.78+0.46 (+2.04%) ▲|COF199.94-0.76 (-0.38%) ▼|COP110.10+0.40 (+0.36%) ▲|COST961.91+10.56 (+1.11%) ▲|CRM152.59+2.47 (+1.65%) ▲|CSCO119.59-1.94 (-1.60%) ▼|CVS101.82+0.52 (+0.51%) ▲|CVX175.65+0.59 (+0.34%) ▲|DE598.23-0.36 (-0.06%) ▼|DHR178.17-0.03 (-0.01%) ▼|DIS103.11+0.66 (+0.64%) ▲|DUK125.20+1.68 (+1.36%) ▲|EMR144.49-5.72 (-3.81%) ▼|FDX322.87-5.91 (-1.80%) ▼|GD348.01+4.65 (+1.35%) ▲|GE357.11+1.99 (+0.56%) ▲|GEV1,051.83-75.76 (-6.72%) ▼|GILD126.09+1.22 (+0.97%) ▲|GM79.48-0.96 (-1.19%) ▼|GOOG346.16-2.62 (-0.75%) ▼|GOOGL346.70-2.86 (-0.82%) ▼|GS1,099.85-6.52 (-0.59%) ▼|HD327.00+0.38 (+0.12%) ▲|HON224.81-3.31 (-1.45%) ▼|IBM265.24+13.02 (+5.16%) ▲|INTC135.87-5.07 (-3.60%) ▼|INTU260.03+2.26 (+0.87%) ▲|ISRG399.69-3.27 (-0.81%) ▼|JNJ235.47+4.18 (+1.81%) ▲|JPM334.79+3.31 (+1.00%) ▲|KO80.15+0.62 (+0.78%) ▲|LIN518.02+1.31 (+0.25%) ▲|LLY1,100.45-1.63 (-0.15%) ▼|LMT500.55+6.95 (+1.41%) ▲|LOW214.97+0.57 (+0.27%) ▲|LRCX368.16-41.39 (-10.11%) ▼|MA487.83+3.74 (+0.77%) ▲|MCD272.33+2.23 (+0.82%) ▲|MDLZ60.76+1.25 (+2.09%) ▲|MDT80.40+1.13 (+1.43%) ▲|META564.13+0.28 (+0.05%) ▲|MMM162.64-0.58 (-0.36%) ▼|MO71.09+1.58 (+2.27%) ▲|MRK118.26+2.78 (+2.41%) ▲|MS226.68-0.42 (-0.18%) ▼|MSFT374.62+7.28 (+1.98%) ▲|MU1,084.53-126.85 (-10.47%) ▼|NEE86.68+0.60 (+0.69%) ▲|NFLX72.69-0.19 (-0.26%) ▼|NKE42.42-0.77 (-1.78%) ▼|NOW96.71+3.70 (+3.98%) ▲|NVDA200.95-7.71 (-3.69%) ▼|ORCL170.02-5.06 (-2.89%) ▼|PEP141.65+0.94 (+0.67%) ▲|PFE24.87-0.21 (-0.84%) ▼|PG150.78+3.10 (+2.10%) ▲|PLTR118.58-0.92 (-0.77%) ▼|PM178.41+5.24 (+3.02%) ▲|QCOM199.77-22.13 (-9.97%) ▼|RTX183.96+2.13 (+1.17%) ▲|SBUX99.96-0.19 (-0.19%) ▼|SCHW92.83+0.80 (+0.87%) ▲|SO94.82+1.39 (+1.48%) ▲|SPG216.89+2.32 (+1.08%) ▲|T22.61+0.51 (+2.29%) ▲|TMO464.96+0.95 (+0.20%) ▲|TMUS182.64+2.58 (+1.43%) ▲|TSLA384.84-20.21 (-4.99%) ▼|TXN304.90-27.38 (-8.24%) ▼|UBER70.45-0.99 (-1.38%) ▼|UNH404.19-2.50 (-0.61%) ▼|UNP261.09+1.18 (+0.45%) ▲|UPS106.43-0.81 (-0.76%) ▼|USB59.60+0.92 (+1.57%) ▲|V330.90+4.30 (+1.32%) ▲|VZ46.09+0.73 (+1.60%) ▲|WFC84.02+0.18 (+0.21%) ▲|WMT119.63+2.45 (+2.09%) ▲|XOM139.47+1.00 (+0.72%) ▲|AAPL299.43+2.42 (+0.81%) ▲|ABBV234.34+4.33 (+1.88%) ▲|ABT90.27+2.44 (+2.77%) ▲|ACN126.48+1.65 (+1.32%) ▲|ADBE196.81+1.91 (+0.98%) ▲|AMAT582.66-57.52 (-8.99%) ▼|AMD521.69-29.94 (-5.43%) ▼|AMGN347.21+2.49 (+0.72%) ▲|AMT176.94+0.51 (+0.29%) ▲|AMZN234.09+1.30 (+0.56%) ▲|AVGO380.98-11.16 (-2.84%) ▼|AXP337.82-0.26 (-0.08%) ▼|BA218.75-2.08 (-0.94%) ▼|BAC57.84+0.47 (+0.82%) ▲|BKNG167.94+0.17 (+0.10%) ▲|BLK1,030.89-20.85 (-1.98%) ▼|BMY55.38+0.68 (+1.24%) ▲|BNY147.98+1.54 (+1.05%) ▲|BRK-B493.71+5.02 (+1.03%) ▲|C145.82+0.15 (+0.10%) ▲|CAT986.47-35.82 (-3.50%) ▼|CL90.92+2.25 (+2.54%) ▲|CMCSA22.78+0.46 (+2.04%) ▲|COF199.94-0.76 (-0.38%) ▼|COP110.10+0.40 (+0.36%) ▲|COST961.91+10.56 (+1.11%) ▲|CRM152.59+2.47 (+1.65%) ▲|CSCO119.59-1.94 (-1.60%) ▼|CVS101.82+0.52 (+0.51%) ▲|CVX175.65+0.59 (+0.34%) ▲|DE598.23-0.36 (-0.06%) ▼|DHR178.17-0.03 (-0.01%) ▼|DIS103.11+0.66 (+0.64%) ▲|DUK125.20+1.68 (+1.36%) ▲|EMR144.49-5.72 (-3.81%) ▼|FDX322.87-5.91 (-1.80%) ▼|GD348.01+4.65 (+1.35%) ▲|GE357.11+1.99 (+0.56%) ▲|GEV1,051.83-75.76 (-6.72%) ▼|GILD126.09+1.22 (+0.97%) ▲|GM79.48-0.96 (-1.19%) ▼|GOOG346.16-2.62 (-0.75%) ▼|GOOGL346.70-2.86 (-0.82%) ▼|GS1,099.85-6.52 (-0.59%) ▼|HD327.00+0.38 (+0.12%) ▲|HON224.81-3.31 (-1.45%) ▼|IBM265.24+13.02 (+5.16%) ▲|INTC135.87-5.07 (-3.60%) ▼|INTU260.03+2.26 (+0.87%) ▲|ISRG399.69-3.27 (-0.81%) ▼|JNJ235.47+4.18 (+1.81%) ▲|JPM334.79+3.31 (+1.00%) ▲|KO80.15+0.62 (+0.78%) ▲|LIN518.02+1.31 (+0.25%) ▲|LLY1,100.45-1.63 (-0.15%) ▼|LMT500.55+6.95 (+1.41%) ▲|LOW214.97+0.57 (+0.27%) ▲|LRCX368.16-41.39 (-10.11%) ▼|MA487.83+3.74 (+0.77%) ▲|MCD272.33+2.23 (+0.82%) ▲|MDLZ60.76+1.25 (+2.09%) ▲|MDT80.40+1.13 (+1.43%) ▲|META564.13+0.28 (+0.05%) ▲|MMM162.64-0.58 (-0.36%) ▼|MO71.09+1.58 (+2.27%) ▲|MRK118.26+2.78 (+2.41%) ▲|MS226.68-0.42 (-0.18%) ▼|MSFT374.62+7.28 (+1.98%) ▲|MU1,084.53-126.85 (-10.47%) ▼|NEE86.68+0.60 (+0.69%) ▲|NFLX72.69-0.19 (-0.26%) ▼|NKE42.42-0.77 (-1.78%) ▼|NOW96.71+3.70 (+3.98%) ▲|NVDA200.95-7.71 (-3.69%) ▼|ORCL170.02-5.06 (-2.89%) ▼|PEP141.65+0.94 (+0.67%) ▲|PFE24.87-0.21 (-0.84%) ▼|PG150.78+3.10 (+2.10%) ▲|PLTR118.58-0.92 (-0.77%) ▼|PM178.41+5.24 (+3.02%) ▲|QCOM199.77-22.13 (-9.97%) ▼|RTX183.96+2.13 (+1.17%) ▲|SBUX99.96-0.19 (-0.19%) ▼|SCHW92.83+0.80 (+0.87%) ▲|SO94.82+1.39 (+1.48%) ▲|SPG216.89+2.32 (+1.08%) ▲|T22.61+0.51 (+2.29%) ▲|TMO464.96+0.95 (+0.20%) ▲|TMUS182.64+2.58 (+1.43%) ▲|TSLA384.84-20.21 (-4.99%) ▼|TXN304.90-27.38 (-8.24%) ▼|UBER70.45-0.99 (-1.38%) ▼|UNH404.19-2.50 (-0.61%) ▼|UNP261.09+1.18 (+0.45%) ▲|UPS106.43-0.81 (-0.76%) ▼|USB59.60+0.92 (+1.57%) ▲|V330.90+4.30 (+1.32%) ▲|VZ46.09+0.73 (+1.60%) ▲|WFC84.02+0.18 (+0.21%) ▲|WMT119.63+2.45 (+2.09%) ▲|XOM139.47+1.00 (+0.72%) ▲|
20.6 C
New York
Tuesday, June 23, 2026

Tag: experience

newssourceFORcompanyinformationcontent1marketreleases

MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).

AESC and Prevalon Energy Sign 10+ GWh Strategic Supply Agreement to Support Global Energy Storage Growth

SHANGHAI, June 13, 2026 /PRNewswire/ -- AESC, a global leader in high-performance batteries and energy storage systems, and Prevalon Energy, a Mitsubishi Power Americas...

AESC and Prevalon Energy Sign 10+ GWh Strategic Supply Agreement to Support Global Energy Storage Growth

SHANGHAI, June 13, 2026 /PRNewswire/ -- AESC, a global leader in high-performance batteries and energy storage systems, and Prevalon Energy, a Mitsubishi Power Americas...

KFSH Showcases Trusted AI as the Foundation for Scalable Healthcare Transformation at HLTH Europe 2026

RIYADH, Saudi Arabia, June 13, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will use its participation at HLTH Europe 2026, taking place from June 15 to 18 in Amsterdam, to advance a clear message: artificial intelligence in healthcare will only scale when institutions can prove that it is safe, reliable, governed, and trusted by clinicians and patients.

Ripple’s XRP Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement

Join XRP and top assets through AI-driven automated strategies with daily settlement—no manual trading needed. 
Join XRP and top assets through AI-driven automated strategies with daily settlement—no manual trading needed.

YEEDI Delivers Lowest-Ever Pricing on Self-Cleaning Roller Mop Robot Vacuums With Early Prime Day Deals

Starting June 13, M14 PLUS and S14 PLUS Drop to $399.99, Bringing Advanced Self-Cleaning Roller Mop Technology Into the Sub-$400 SegmentSAN FRANCISCO, June 13,...

VEVOR Launches “Beat the Heat at Home” Summer Comfort Lineup for Outdoor Living

HOUSTON, June 13, 2026 /PRNewswire/ -- As summer temperatures climb, staying cool at home shouldn't require a sky-high electric bill, a cooler full of...

 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat mass with preservation of lean mass, and improvements in hyperphagia and anxiety measures --   

-- Positive results reinforce rationale for Phase 3 development of MC4R agonism in PWS --

AESC and Prevalon Energy Sign 10+ GWh Strategic Supply Agreement to Support Global Energy Storage Growth

SHANGHAI, June 13, 2026 /PRNewswire/ -- AESC, a global leader in high-performance batteries and energy storage systems, and Prevalon Energy, a Mitsubishi Power Americas...

New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

BEERSE, BELGIUM, June 13, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced results from the investigational Phase 3 MonumenTAL-3 study.1 The results showed that TALVEY® (talquetamab), a GPRC5D bispecific antibody, in combination with daratumumab with or without pomalidomide demonstrated significant reduction in the risk of disease progression or death of up to 72.0%, and clinically meaningful reduction of up to 53.0% in the risk of death, compared to the standard regimen of daratumumab, pomalidomide, and dexamethasone (DPd) in patients with relapsed or refractory multiple myeloma (RRMM).1 Results showed a progression-free survival (PFS) rate of up to 81.3% versus standard of care (51.2%) and an overall survival (OS) rate of up to 89.2% versus standard of care (79.1%) at 24 months.1  

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma

TALVEY® plus DARZALEX FASPRO® with or without pomalidomide showed progression-free survival of up to 81% and overall survival of up to 89% at 24 monthsMonumenTAL-3 is the...

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies , a global provider of IT solutions and services, today opened a...

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies , a global provider of IT solutions and services, today opened a...

EpiCooler Product Information Updated As Consumer Interest In Portable AC Grows In 2026

Kaunas, Lithuania, June 13, 2026 (GLOBE NEWSWIRE) --

An informational overview examining EpiCooler Portable AC Product Details, Publicly available product disclosures and what consumers often consider when researching portable cooling devices in 2026

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsExperience

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers